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Axon growth is essential for the establishment 
of a functional nervous system as well as for the 
restoration of neuronal connectivity after injury 
or disease. It has long been hypothesized that re-
activation of developmental growth mechanisms 
might help to achieve axon regeneration in the 
injured adult nervous system (Filbin, 2006). The 
role of MAP kinases in axon growth signaling 
has been much studied and discussed (Markus 
et al., 2002; Hanz and Fainzilber, 2006; Agthong   
et al., 2009; Hollis et al., 2009). However, depend-
ing on the model systems used, the outcomes 
have been controversial or even contradictory 
(Pernet et al., 2005; Sapieha et al., 2006; Hollis 
et al., 2009). We have shown that RAF–MEK 
signaling robustly promotes axon growth in pri-
mary sensory neurons in vitro (Markus et al., 
2002). In vivo, conditional gene targeting studies 
have shown that RAF signaling is necessary for 
developing sensory neurons to arborize in their 
target fields in the skin (Zhong et al., 2007). 
However, it remains unknown whether RAF sig-
naling is sufficient to enable axon growth in vivo 
or whether concomitant activation of other 
signaling pathways is necessary to drive long-
range axon projections. Furthermore, it is un-
clear whether this pathway can promote axon 
growth in neuronal populations beyond the sen-
sory neurons and the extent to which it can be 
harnessed to promote regeneration in the in-
jured central nervous system (CNS). To address 
these questions, we have used conditional B-RAF 
gain-of-function mouse models to show that 
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Activation of intrinsic growth programs that promote developmental axon growth may also 
facilitate axon regeneration in injured adult neurons. Here, we demonstrate that condi-
tional activation of B-RAF kinase alone in mouse embryonic neurons is sufficient to drive 
the growth of long-range peripheral sensory axon projections in vivo in the absence of 
upstream neurotrophin signaling. We further show that activated B-RAF signaling enables 
robust regenerative growth of sensory axons into the spinal cord after a dorsal root crush 
as well as substantial axon regrowth in the crush-lesioned optic nerve. Finally, the combi-
nation of B-RAF gain-of-function and PTEN loss-of-function promotes optic nerve axon 
extension beyond what would be predicted for a simple additive effect. We conclude that 
cell-intrinsic RAF signaling is a crucial pathway promoting developmental and regenerative 
axon growth in the peripheral and central nervous systems.
© 2014 O’Donovan et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is   
available under a Creative Commons License (Attribution–Noncommercial–Share   
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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peripheral axons into the epidermis. To examine whether 
RAF signaling alone is sufficient to promote long-range axon 
extension of TrkA-positive neurons, we set out to selectively 
activate RAF kinase signaling in these neurons in a TrkA-
null background.
To this end, we first conditionally activated RAF signaling 
in a WT background using a genetically modified loxP-STOP-
loxP-BrafV600E (LSL-kaBraf) knock-in mouse line (Mercer et al., 
2005), in which a kinase-activated B-RAF (kaB-RAF) mutant 
is expressed from the endogenous B-RAF locus upon Cre 
recombination. We next bred LSL-kaBraf mice with a neuronal 
activation of intraneuronal RAF–MEK signaling is sufficient to 
promote robust axon growth in developing and regenerating 
neurons in the peripheral nervous system and CNS.
RESULTS
Activation of B-RAF signaling alone is sufficient to promote 
sensory axon extension during early development
In vivo, the neurotrophin nerve growth factor (NGF) signals 
through its receptor kinase TrkA to promote developmental 
extension of dorsal root ganglion (DRG) nociceptive TrkA+ 
Figure 1.  Conditional expression of kaB-
RAF specifically activates MAP kinase 
signaling in the nervous system. (A) E18.5 
mouse embryos expressing kaB-RAF develop 
grossly normally, except for substantial hy-
drocephalus. (B) DRG size is unaffected by 
kaB-RAF expression. (C) Representative West-
ern blots show increased levels of pMEK1/2 
and pERK1/2 in the E12.5 neocortex and spi-
nal cord. (D) Quantitation of Western blots as 
in C. Amounts are normalized to correspond-
ing III-tubulin levels. n = 4 repeats with 
three animals per group for each bar. Stu-
dent’s t test: *, P < 0.05; **, P < 0.01. (E–G) 
Analysis of the interaction of kaB-RAF with 
other signaling pathways in the E12.5 nervous 
system. Representative Western blots are 
from three independent experiments, each 
with two or three E12.5 embryos for each 
genotype. (G) B-RAF protein levels are not 
increased in E12.5 DRG and spinal cord of 
LSL-kaBraf:nesCre embryos and control  
littermates. Molecular mass is indicated in 
kilodaltons. (H) Representative images of 
nerve endings in trunk skin of E13.5 embryos. 
Bars: (B) 200 µm; (H) 40 µm. (I) The number of 
branches per nerve trunk was quantitated, 
blinded to the genotypes, for a defined skin 
section by counting the total number of 
branch points observed along each major 
nerve trunk entering the skin (Zhong et al., 
2007). n = 3 for each group. (D and I) Error 
bars indicate SEM.JEM Vol. 211, No. 5 
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(Fig. 1, C and D). Note that compared with MEK1/2, ERK1/2 
activation appears minor in the kaB-RAF–expressing DRGs; 
this is because of relatively high levels of pERK1/2 in the DRG 
at baseline. B-RAF activation did not affect mTOR phosphory-
lation (Fig. 1 E). Levels of pAKT, pS6K, and pGSK3 were 
not changed significantly in the DRG of LSL-kaBraf:nes-Cre 
mice (Fig. 1 F), indicating minimal cross talk between the MAP 
kinase and PI3-kinase–AKT pathways. Because the expression 
of kaB-RAF is under the control of endogenous Braf pro-
moter, the expression level of B-RAF protein is not changed in 
nestin promoter-driven Cre deleter (nes-Cre; Tronche et al., 
1999). In DRG neurons, nes-Cre–mediated recombination oc-
curs as early as embryonic day (E) 11.5 (Galabova-Kovacs et al., 
2008). Embryos heterozygously expressing kaB-RAF progres-
sively developed macrocephaly from E13.5 onwards (Fig. 1 A) 
but appeared otherwise normal, including normally sized 
DRGs (Fig. 1 B). The known RAF effectors were activated 
in neuronal tissues expressing Cre recombinase, as indicated by 
elevated phospho-MEK1/2 (pMEK1/2) and pERK1/2 in the 
neocortex and spinal cord of E12.5 LSL-kaBraf:nes-Cre mice 
Figure 2.  Expression of kaB-RAF substantially rescues sensory afferent growth in the absence of TrkA/NGF signaling. (A, left) Normal sensory 
cutaneous innervation at E16.5. (middle) Sensory cutaneous innervation is lost in embryos lacking the NGF receptor TrkA. (right) Expression of kaB-RAF 
restores cutaneous innervation. Arrowheads label the blue -gal–positive (presumptive TrkA+) sensory trajectories. (B) Visualization of axon growth pat-
terns after tissue clearing. The thoracic somatosensory innervation driven by kaB-RAF in a TrkA/ embryo (bottom; compare with middle for TrkA/ 
alone) is similar to that seen in a control TrkAWT/ littermate (top). White arrowheads indicate the normal pathways of peripheral axons extending from 
thoracic DRGs. Red arrowheads indicate sensory projections rescued by kaB-RAF in the TrkA/ background. (C) Expression of kaB-RAF substantially res-
cues trigeminal TrkA+ afferent growth in the absence of TrkA/NGF signaling. Presumptive TrkA+ trigeminal axon projections (top) are lost in TrkA-deficient 
mice (middle) and are rescued by kaB-RAF (bottom). Ga, great auricular nerve; Go, greater occipital nerve; Mn, mandibular branch; Mx, maxillary branch; 
Op, ophthalmical branch. Images show littermates and are representative of three embryos per genotype. Bars: (A) 2 mm; (B and C) 1 mm.804 B-RAF drives axon growth and regeneration | O’Donovan et al.
(which include LSL-kaBraf:TrkA/:Bax/, nes-Cre:TrkA/:
Bax/, and TrkA/:Bax/ genotypes), in which we detected 
no LacZ-positive fibers in the skin at E16.5, expression of kaB-
RAF in TrkA/:Bax/ DRG and trigeminal neurons sub-
stantially restored cutaneous sensory axon projections (Fig. 2, 
A–C). The morphologies of the radial thoracic trajectories de-
rived from spinal DRGs as well as those growing from tri-
geminal ganglia induced by kaB-RAF in the TrkA/:Bax/ 
background were grossly similar to those seen in control mice. 
Epidermal innervation of the footpad was partially rescued by 
kaB-RAF (Fig. 3, A and B). Thus, sustained B-RAF kinase 
activity can, to a large extent, substitute for TrkA-mediated 
axon growth signaling in presumptive TrkA+ sensory neurons.
B-RAF–mediated axon growth indirectly rescues  
calcitonin gene-related peptide (CGRP) expression  
in TrkA/:Bax/ neurons
CGRP expression in the peptidergic subset of nociceptive 
DRG neurons is induced by skin-derived factors and there-
fore indicates that sensory axon peripheral innervation into 
the skin is complete (Hall et al., 1997, 2001; Patel et al., 2000; 
Xu and Hall, 2007). In TrkA/:Bax/ mice, DRG neu-
rons and their centrally projecting axons are devoid of CGRP 
because of the lack of cutaneous innervation as previously de-
scribed (Patel et al., 2000), whereas CGRP expression in the 
spinal motor neurons remains unaffected (Fig. 4 A, middle). 
the DRG and spinal cord at E12.5 (Fig. 1 G). At E13.5, the 
branching pattern of sensory nerves in the skin was not changed 
by kaB-RAF expression (Fig. 1, H and I).
B-RAF activation rescues nociceptor axon  
extension in embryos lacking TrkA
To test whether kaB-RAF is sufficient to drive nociceptor 
axon growth in the absence of TrkA signaling, we next mated 
the LSL-kaBraf:nes-Cre line with available TrkAtaulacZ and 
Bax/ lines to generate LSL-kaBraf:TrkAtaulacZ/taulacZ:Bax/:
nes-Cre mice. In TrkAtaulacZ mice, the WT TrkA gene is re-
placed by a taulacZ expression cassette, such that the axonal 
morphology of putative TrkA+ neurons can be visualized by 
-gal staining (Moqrich et al., 2004). Because TrkA expres-
sion is absent in homozygous TrkAtaulacZ/taulacZ mice, we refer 
to the “TrkAtaulacZ/taulacZ” as “TrkA/” in the text below. Re-
moval of the Bax gene blocks apoptosis in embryonic DRG 
neurons, rescuing them from cell death that is otherwise ob-
served in the absence of TrkA signaling. The Bax/ back-
ground thus allows for the molecular dissection of signaling 
pathways that specifically affect axon growth (Knudson et al., 
1995; Lentz et al., 1999; Patel et al., 2000; Markus et al., 2002; 
Kuruvilla et al., 2004; Moqrich et al., 2004). In TrkA/:
Bax/ mice, DRG neurons survive, but sensory afferent in-
nervation in the skin is completely abolished (Fig. 2, A and B, 
middle; Patel et al., 2000). Compared with control littermates 
Figure 3.  Axon terminal innervation of 
E18.5 footpad. (A, top) Normal innervation. 
(middle) In the absence of TrkA, innervation is 
diminished overall, and the CGRP-positive 
nociceptor endings are completely absent. 
Red arrowheads indicate the CGRP-positive 
axon terminals in the epidermis. (bottom) 
kaB-RAF expression partially rescues nocicep-
tive innervation in the TrkA/ background. 
The dashed lines indicate the dermal–epidermal 
border. Bar, 100 µm. (B) Quantification of 
axon innervation in footpad (Luo et al., 2007; 
Hancock et al., 2011). Data are from three 
fetuses per genotype. Error bars indicate SEM. 
One-way ANOVA with post-hoc Tukey’s HSD 
test: **, P < 0.01.JEM Vol. 211, No. 5 
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Specifically, nociceptive TrkA+ fibers terminate in the superfi-
cial laminae I and II of the dorsal horn, and proprioceptive parv-
albumin-positive afferents project to intermediate laminae or to 
the ventral spinal cord.
In B-RAF gain-of-function mice, we observed excessive 
growth of both nociceptive and proprioceptive afferents (Fig. 5). 
Nociceptive axons normally restricted to superficial dorsal 
horn extended ectopically into deeper layers of dorsal spinal 
cord, and many axons aberrantly crossed the midline (Fig. 5 A). 
This kaB-RAF–driven overgrowth was substantially rescued 
by concomitant elimination of MEK1/2, the canonical down-
stream kinases of RAF (Fig. 5 C), suggesting that the effect of 
kaB-RAF expressed from the endogenous Braf locus depends 
strictly on canonical signaling.
In WT mice, the central proprioceptive afferents enter the 
cord medially at tightly circumscribed dorsal root entry zones 
(DREZs; Fig. 5 B, left). kaB-RAF expression caused the pro-
prioceptive sensory axons to enter the spinal cord all across   
its surface and to aberrantly terminate some branches in the 
superficial dorsal laminae (Fig. 5 B, right). Proprioceptive 
axons in the DREZs normally are subject to repulsive guid-
ance from Semaphorin 6C/D (Sema6) expressed in the spi-
nal cord, acting on PlexinA1 on the sensory axons (Yoshida 
et al., 2006). kaB-RAF expression did not detectably alter the 
protein (Fig. 5 D) or transcript levels (RNAseq; not depicted) 
B-RAF gain-of-function restored CGRP expression in the 
absence of TrkA (Fig. 4 A, right). Note also that in contrast 
to the projections in the periphery, the growth of presumptive 
TrkA-positive afferent projections in the dorsal horn is inde-
pendent of TrkA signaling (Fig. 4 B, middle; Patel et al., 2000; 
Harrison et al., 2004) and that kaB-RAF expression caused 
overgrowth of these afferents (Fig. 4 B, right) but not of pe-
ripheral projections (Fig. 1). In vitro, kaB-RAF alone did not 
induce CGRP expression in DRG neurons (Fig. 4 C, top); 
this required the addition of NGF and skin-conditioned me-
dium as previously reported (Fig. 4 C, bottom; Hall et al., 1997; 
Patel et al., 2000; Xu and Hall, 2007). In addition, we have 
shown previously that loss of both B- and C-RAF in DRGs 
does not abrogate the CGRP expression (Zhong et al., 2007). 
These data together indicate that the restoration of CGRP 
expression in LSL-kaBraf:nes-Cre:TrkA/:Bax/ DRG neu-
rons is not directly caused by the elevation of neuron-intrinsic 
B-RAF activity, but indirectly through the restoration of cu-
taneous innervation and subsequent retrograde signaling from 
skin-derived factors.
kaB-RAF causes overgrowth of nociceptive  
and proprioceptive afferent fibers in the spinal cord
In WT mice, different subpopulations of sensory neurons pro-
ject from the DRG to highly specific targets in the spinal cord. 
Figure 4.  Activation of B-RAF indirectly 
rescues CGRP expression in TrkA/ noci-
ceptive neurons. (A, left) Normal CGRP stain-
ing in the DRG and superficial dorsal horn. 
Arrowhead indicates CGRP-expressing spinal 
motoneurons. (middle) CGRP expression is 
completely abolished in the DRG and its  
projections in TrkA/Bax double-null mice.  
CGRP staining in spinal motoneurons is not 
affected by loss of TrkA signaling (arrowhead). 
(right) CGRP expression in DRG is rescued by 
expression of kaB-RAF, in the absence of TrkA 
signaling (LSL-kaBraf:nes-Cre:TrkA/:Bax/). 
Arrowhead indicates the CGRP+ motor neu-
rons. Dashed white lines outline the spinal cord 
and DRG. (B) The nociceptive projection into 
the dorsal horn (left) does not depend on TrkA 
(middle). Expression of kaB-RAF causes over-
growth and ectopic targeting of these fibers 
(right). (A and B) Images are representative of 
three embryos each. (C) Activation of B-RAF 
does not directly induce CGRP expression in 
cultured DRG neurons. (top) No CGRP is ex-
pressed in 7-d in vitro cultures of dissociated 
E12.5 LSL-kaBraf:Bax/:nes-Cre DRG neu-
rons. (bottom) NGF and conditioned medium 
from skin cultures are necessary to induce 
CGRP expression in E12.5 LSL-kaBraf:Bax/:
nes-Cre DRG neurons. Images are representa-
tive of three independent experiments. This 
experiment has been repeated three times. 
Each experiment used two embryos per geno-
type. Bars: (A and B) 100 µm; (C) 20 µm.806 B-RAF drives axon growth and regeneration | O’Donovan et al.
phenotype suggested that reactivation of the B-RAF path-
way in injured adult neurons might be exploited to pro-
mote regeneration.
of these factors in E12.5 DRG and spinal cord. The overgrowth 
phenotype for both nociceptive and proprioceptive afferents 
was observed at all levels of the spinal cord (Fig. 5, E–J). This 
Figure 5.  Activation of B-RAF drives overgrowth of centrally projecting nociceptive and proprioceptive DRG axons in the E18.5 spinal 
cord. (A) Nociceptive projections stained for TrkA. Yellow arrowheads indicate the different patterns of axon projections of WT and kaB-RAF–express-
ing, nociceptive neurons. (B) Proprioceptive projections stained for parvalbumin. White arrowheads indicate the different patterns of axon projections 
of WT and kaB-RAF–expressing, proprioceptive neurons. Asterisks label the presumptive DREZs. (C) kaB-RAF–driven overgrowth of central nociceptive 
projections (left) is abolished in the absence of the downstream effectors MEK1/MEK2 (right). (A–C) n = 3 per genotype. (D) kaB-RAF does not affect 
the expression of known guidance cues PlexinA1 and Sema6D in the E12.5 DRG and spinal cord. Western blot is representative of three indepen-
dent experiments, each with two embryos per genotype. Molecular mass is indicated in kilodaltons. (E–J) Cross sections of P0 spinal cord at cervical  
(E and H), thoracic (F and I), and lumbar (G and J) levels were stained for CGRP, parvalbumin (Parv), and Draq5 (blue). Bars: (A and B) 200 µm;  
(C) 100 µm; (E–J) 50 µm.JEM Vol. 211, No. 5 
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Figure 6.  Activation of B-RAF signaling in mature DRG neurons elevates their growth competency. (A, top) Schematic of the brn3a-CreERT2 
construct used to generate the brn3a-CreERT2 deleter mouse line. (bottom) A cross section of the spinal cord of a 10-wk-old Rosa26-lacZ:brn3a-
CreERT2 mouse treated with tamoxifen. Blue LacZ staining indicates CreERT2-medicated recombination in the DRG neurons. (B) Representative DRGs 
from adult LSL-kaBraf:TdTom:brn3a-CreERT2 mice without (top left) and with (bottom left) tamoxifen treatment. TdTom expression indicates recom-
bination in DRG neurons. Cells were counterstained with Draq5 (Dq5) to label nuclei. (C) ATF3 is induced by preconditioning lesion. Blue shows nu-
clear stain Draq5. (D) Representative images of adult DRG neurons derived from intact brn3a-CreERT2:TdTom (left), LSL-kaBraf:brn3aCreERT2:TdTom  808 B-RAF drives axon growth and regeneration | O’Donovan et al.
kaB-RAF enables regeneration of injured adult  
DRG central axons across the DREZ
To test whether activation of B-RAF signaling can drive ma-
ture sensory axon regeneration, we generated LSL-kaBraf:
TdTomato (TdTom):brn3a-CreERT2 mice to inducibly express 
kaB-RAF in adult DRG neurons. The brn3a-CreERT2 deleter 
mouse line was generated using a brn3a promoter (Eng et al., 
2001), which mediates expression selectively in sensory neu-
rons (Fig. 6 A). We first assessed B-RAF gain-of-function in 
cultured adult neurons. 12-wk-old mice were treated with 
tamoxifen for a consecutive 5 d to induce kaB-RAF expres-
sion, as indicated by TdTom expression (Fig. 6 B). ATF3, a 
marker whose expression is triggered by conditioning lesion 
(Smith and Skene, 1997; Seijffers et al., 2007) was not induced 
(Fig. 6 C). DRG neurons were cultured for up to 24 h. kaB-
RAF expression correlated with both greatly increased num-
bers of axon-bearing neurons and increased total axon length 
with more branching compared with that of WT neurons 
(Fig. 6, D–G). Furthermore, the axonal morphology of kaB-
RAF–expressing neurons differs from WT neurons subject to 
a preconditioning lesion, which exhibited single long axons 
(Fig. 6, D and H).
Having  thus  ascertained  the  functionality  of  the  LSL-
kaBraf:TdTom:brn3a-CreERT2  mouse  line,  we  next  tested 
whether kaB-RAF can enable axon regeneration after dorsal 
root crush injury in vivo. 12-wk-old mice were again treated 
with tamoxifen for a consecutive 5 d. After 2-d rest, C5–8 
cervical roots were crushed and AAV2-GFP was injected to 
C6 and C7 DRGs to label regenerating sensory axons. After 
2 wk, regeneration in the C6 and C7 roots and spinal cord 
was examined in whole-mount preparations (Fig. 7, A and B) 
or in transverse sections (Fig. 7, C and D). As expected, in 
control brn3a-CreERT2 mice (Fig. 7, A and C), axons regener-
ated along the roots but stopped at the DREZ. In contrast, in 
mice with kaB-RAF expression in DRG neurons, numerous 
axons penetrated the DREZ and grew deeply into the spinal 
cord, exhibiting dense collateral branches in the dorsal col-
umn (Fig. 7 B) and reaching superficial laminae of the dorsal 
horn (Fig. 7 D). Thus, elevation of intrinsic B-RAF signaling 
is sufficient, both in vitro and in vivo, to induce robust axon 
regrowth of adult DRG neurons and, importantly, renders the 
axons capable of overcoming growth-inhibitory signals that 
are abundant at the DREZ and within the spinal cord.
kaB-RAF enables regenerative axon growth in the injured 
optic nerve through an MEK-dependent pathway
To test whether activation of B-RAF kinase signaling can pro-
mote axon regeneration of injured mature CNS neurons, we 
used an optic nerve regeneration model (Fig. 8, A and B; Park 
et al., 2008; Benowitz and Yin, 2010). 8–12-wk-old LSL-kaBraf:
Bax/ mice and Bax/ controls were injected intravitreally 
with AAV2-Cre to induce kaB-RAF expression in retinal gan-
glion cells (RGCs) and then subjected to optic nerve crush. The 
Bax/ background was used to minimize apoptotic death of 
retinal ganglion neurons triggered by optic nerve injury, which 
may amount to 80% at 2 wk after optic nerve crush (Li et al., 
2000). 2 wk after the injury, we observed robust regenerative 
axon growth up to 3 mm past the lesion site in the kaB-RAF–
expressing optic nerve (Fig. 8, D and G), with very limited 
growth in the control Bax/ littermates (Fig. 8 C), consistent 
with previous observations that survival alone is not sufficient to 
promote growth of adult RGC axons (Goldberg et al., 2002).
Combined deletion of the canonical RAF effector kinases 
MEK1 and MEK2 substantially suppressed the regenerative 
axon growth caused by kaB-RAF (Fig. 8 E), indicating that 
kaB-RAF drives axon growth through the canonical MEK 
effectors. Whereas the length of axon extension induced by 
(middle), and WT preconditioning lesioned mice (right) after 24 h in vitro. TdTom is shown in green to improve contrast. Bars: (A–C) 100 µm; (D) 20 µm. 
(E–H) Quantitation of axon extension in adult DRG cultures at 24 h in vitro. Data were collected from three independent experiments from three ani-
mals per genotype or condition and analyzed as described previously (Parikh et al., 2011); >100 cells were counted per group. Error bars indicate SEM. 
One-way ANOVA with post-hoc Tukey’s HSD test: *, P < 0.01; **, P < 0.005.
 
Figure 7.  Activation of B-RAF signaling enables crushed sensory 
axons to regenerate into adult spinal cord. (A–D) Confocal views of 
regenerating dorsal root axons in whole mounts (A and B) or transverse 
sections (C and D) 2 wk after root crush. Axons were labeled by AAV-GFP 
injected into C6 and C7 DRGs at the time of the crush injury. (A and C) Con-
trol mice (brn3a-CreERT2). (B and D) Mice expressing activated B-RAF in 
DRGs (LSL-kaBraf:brn3a-CreERT2). Dashed yellow lines indicate the DREZ, 
dashed gray lines indicate the border between gray and white matter, and 
arrowheads indicate the extent of axon growth across the DREZ (B) and 
into gray matter (D). DH, dorsal horn; DR, dorsal root; PNS, peripheral ner-
vous system; SC, spinal cord. n = 2 DRGs from each of three animals per 
genotype. Bars, 200 µm.JEM Vol. 211, No. 5 
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B-RAF gain-of-function is comparable with the maximal 
axon growth reported in PTEN deletion mice (Fig. 8 F; Park 
et al., 2008), in a direct comparison, we found up to a 3.9-fold 
higher density of regenerating axons in the LSL-kaBraf:Bax/ 
mice 1.5 mm distal to the crush site than is seen in the crushed 
Pten/:Bax/ optic nerve (Fig. 8, D, F, and G).
Figure 8.  Activation of B-RAF enables regenerative 
axon growth in the crush-lesioned optic nerve via the 
canonical effectors MEK1/2. (A) Schematic of experimen-
tal time course. (B) Intravitreal injection of AAV2-Cre induces 
expression of TdTom in retinal ganglion neurons, labeling the 
entire optic nerve (red). (C, top) Whole-mount image of a 
crushed Bax/ optic nerve. Crush site is indicated by a red 
asterisk here and in all following panels. (bottom) Confocal 
fluorescence image of the same nerve. Green shows axons 
anterogradely labeled with CTB–Alexa Fluor 488. (D) Whole-
mount confocal imaging shows strong regenerative growth 
in the lesioned kaB-RAF–expressing optic nerve. (inset) Axons 
at 3.5 mm from the crush site (magnified from the boxed 
area). Arrowheads indicate outgrowing axons. (E) Loss of 
MEK1 and MEK2 abolishes the regeneration driven by kaB-RAF. 
(F) Optic nerve regeneration in the absence of PTEN. Bar,  
0.5 mm. (C–F) Images are representative of three optic 
nerves per genotype. (G) Quantitation of axon regenerative 
growth in the optic nerve 2 wk after nerve crush; genotypes 
as shown in B–E. At 1.6 mm from the crush site, the den-
sity of regenerating axons is more than threefold greater in 
the LSL-kaBraf:Bax/ genotype than in the Ptenf/f:Bax/ 
genotype. Data are from three nerves per genotype. Optic 
densities were acquired from the whole-mount optic nerves 
using an LSM710NLO two-photon confocal microscope with 
the ZEN2009 software. Data were normalized by setting the 
baseline OD, as measured 0.2 cm proximal to the crush site 
in all nerves, to the same (arbitrary) level.810 B-RAF drives axon growth and regeneration | O’Donovan et al.
DISCUSSION
An understanding of the mechanisms that drive axon growth 
is important, both to decipher how connectivity develops in 
the nervous system and to develop therapeutic strategies for 
nervous system repair after injury or disease. We show that the 
RAF–MEK axis plays a key role in axon growth signaling. 
Activation of B-RAF in neurons is sufficient to drive sensory 
axon growth in the embryo, to enable adult sensory axons to 
regenerate across the DREZ and further into the spinal cord, 
and to induce robust regeneration of adult retinal axons in 
the injured optic nerve. Both developmental DRG axon 
overgrowth in the spinal cord and mature RGC axon re-
generation in the optic nerve were abrogated by concomitant 
ablation of MEK1 and MEK2. We thus establish classical cell-
autonomous RAF–MEK signaling as a fundamental driver of 
axon growth. We should note that this pathway seems to be 
selective to axon growth signaling because we have never ob-
served that B-RAF activation supports neuronal survival (un-
published data).
In vitro work has long suggested a potential role for RAF–
MEK signaling in axon growth. Previous in vivo data, however, 
have been scarce and controversial. In the retina, for example, 
pharmaceutical inhibition of MEK–ERK signaling abrogated 
optic nerve regeneration supported by FGF2 (Sapieha et al., 
2006). Two putative intracellular activators of RAF signaling, 
BAG1 and Mst3b, have been shown to promote regenerative 
axon growth in the optic nerve (Planchamp et al., 2008; Lorber 
et al., 2009), but the expression of a constitutively active MEK1 
did not drive any regeneration in the optic nerve (Pernet et al., 
2005). Others have concluded that ERK activity promotes 
RGC axon regeneration via an indirect mechanism dependent 
on glial cells (Müller et al., 2009). Although it is likely that mul-
tiple mechanisms, direct as well as indirect, will contribute to 
axon regeneration in the inhibitory environment of the CNS, 
the current cacophonic state of the field is likely caused by the 
mainly indirect approaches of incomplete penetrance that have 
been taken by various laboratories. When using small molecule 
inhibitors or transient viral overexpression of interfering or ac-
tivating constructs, it is difficult to accurately titrate the dose for 
the entire duration of an experiment. We believe that we have 
applied a stringent approach toward activation of RAF signal-
ing in RGCs, and our data argue strongly for a direct positive 
effect of RAF–MEK signaling on axon growth and regenera-
tion of RGCs, as well as in DRG neurons. Possible downstream 
mechanisms beyond the MEK kinases remain speculative at 
this point. Stabilization of microtubules improves axon regen-
eration in a spinal cord injury (SCI) model through both neu-
ron-intrinsic and -extrinsic mechanisms (Hellal et al., 2011), 
and it is likely that activation of RAF–MEK signaling will di-
rectly affect microtubule stability in injured axons via its effects 
on microtubule-regulating enzymes such as HDAC6 (Williams 
et al., 2013). Furthermore, B-RAF has been shown to directly 
interact with tubulin (Bonfiglio et al., 2011). Activation of 
B-RAF signaling is also likely to trigger the expression of axon 
growth–enhancing gene sets in injured neurons. The elucida-
tion of exact mechanisms awaits further study.
kaB-RAF expression and PTEN deletion synergize  
to increase axon regenerative growth
To test whether combined activation of the B-RAF and PI3-
kinase–mTOR pathways can further boost axon growth ca-
pacity in injured adult retinal ganglion neurons, we performed 
the optic nerve regeneration experiments using double LSL-
kaBraf:Ptenf/f mice. Both the numbers and length of regener-
ating axons were increased in the optic nerve of the LSL-kaBraf:
Ptenf/f mice compared with those in single LSL-kaBraf or in 
Ptenf/f mice (Fig. 9 A). The synergistic effect of activating both 
B-RAF and PI3-kinase signaling is most apparent at the long-
est lengths of axon regeneration (Fig. 9 B). Note that the mice 
in these experiments were from a Bax WT background to en-
able direct comparison with the original PTEN deletion data 
(Park et al., 2008); however, this means that possible survival-
promoting effects of the mutant alleles cannot be excluded.
Figure 9.  Combined B-RAF activation and PTEN deletion enables 
long-range axon regeneration. (A) Representative longitudinal sec-
tions of regenerating optic nerve 2 wk after crush injury. Genotypes are 
as indicated. Crush site is indicated by a red asterisk. Bar, 200 µm. (B) Quan-
titation of data as shown in A. Axons were counted as described in Park 
et al. (2008). n = 6 nerves per genotype. Error bars indicate SEM. Two-
way ANOVA tests comparing LSL-kaBraf with Ptenf/f, LSL-kaBraf and 
Ptenf/f with WT, or LSL-kaBraf and Ptenf/f with LSL-kaBraf:Ptenf/f all re-
sulted in p-values < 0.001.JEM Vol. 211, No. 5 
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The extent of regeneration achieved by direct genetic ac-
tivation of specific intracellular signaling pathways, including 
B-RAF, DLK, PI3-kinase–mTOR, KLF, and JAK–STAT path-
ways (Smith et al., 2009; Yan et al., 2009; Park et al., 2010; 
Blackmore et al., 2012; Shin et al., 2012; Lang et al., 2013), com-
pares favorably with what has been reported for application of 
growth factors such as NGF , BDNF , GDNF , and CNTF (Lykissas 
et al., 2007; Zhang et al., 2009; Allen et al., 2013; Leibinger 
et al., 2013). Growth factors as promoters of regeneration are 
hobbled by two major issues. First, the signaling machinery that 
enables growth factors to drive axon growth in the developing 
nervous system is not expressed at sufficient levels in the adult 
nervous system (Hollis et al., 2009). Indeed, growth inhibitory 
signaling molecules such as the SOCS family or phosphatases   
are up-regulated upon maturation (Lu et al., 2002; Smith et al., 
2009; Park et al., 2010; Gatto et al., 2013). Therefore, the most 
promising studies using growth factors have combined them 
with genetic intervention to up-regulate growth factor receptors 
or down-regulate their intrinsic inhibitors (Hollis et al., 2009; 
Sun et al., 2011). The second issue is that of undesirable side ef-
fects, especially that of neuropathic pain caused by neurotrophin 
administration (Obata et al., 2006; Jankowski and Koerber, 2009). 
Development of “painless” neurotrophins (Capsoni et al., 2011) 
may improve the usefulness of this family of growth factors in the 
context of regeneration. Future combined activation of several 
growth signaling pathways with blockade of growth inhibitory 
pathways may lead to realistic treatment options for patients with 
loss of vision, sensation, or locomotion.
MATERIALS AND METHODS
Mouse models. Mouse breeding and genotyping were performed as de-
scribed previously (Mercer et al., 2005; Zhong et al., 2007). The animal proto-
col was approved by the Institutional Animal Care and Use Committee at Weill 
Cornell Medical College, and experiments were conducted in accordance with 
the National Institutes of Health Guide for the Use and Care of Laboratory 
Animals. The LSL-kaBraf mouse line was provided by C.A. Pritchard (Univer-
sity of Leicester, Leicester, England, UK; Mercer et al., 2005). The TrkAtaulacZ 
mouse was provided by L. Reichardt (University of California, San Francisco, 
San Francisco, CA; Moqrich et al., 2004). Nestin-Cre deleter and Bax-null 
mice were generated in R. Klein’s laboratory (Max Planck Institute of Neuro-
biology, Martinsried, Germany; Tronche et al., 1999) and S.J. Korsmeyer’s labo-
ratory (Dana-Farber Cancer Institute, Boston, MA; Knudson et al., 1995), 
respectively. The brn3a-CreERT2 deleter mouse line was generated by J. Zhong 
in W.D. Snider’s laboratory (University of North Carolina at Chapel Hill, 
Chapel Hill, NC). All mice were on a mixed 129Sv and C57BL/6 background. 
We used littermates as controls throughout.
Generation of the brn3a-CreERT2 deleter mouse line. Brn3a is a POU 
domain transcription factor that is selectively expressed in DRG neurons. 
Using a brn3a promoter construct (Eng et al., 2001), we generated a brn3a-Cre-
ERT2 deleter mouse line using the pronuclear injection technique (Fig. 6 A).
Western blotting and immunohistochemical staining. Western blot-
ting and immunohistochemical staining were performed as described previ-
ously (Zhong et al., 2007). An equal amount of total protein was loaded in 
each lane. The antibodies used were as follows: TrkA, Brn3a, and PlexinA1 
antibodies were provided by L. Reichardt, E. Turner (University of Califor-
nia, San Diego, La Jolla, CA), and T. Jessell (Columbia University, New York, 
NY), respectively. Antibodies against MEK1/2 (9122), pMEK1/2 (9121), 
ERK1/2 (9102), pERK1/2 (9101), pAKT (9271 and 9275), phospho-p70S6K 
The  developmental  phenotypes  we  observed  in  the   
B-RAF gain-of-function embryos were generally comple-
mentary to those previously observed in B-RAF/C-RAF 
loss-of-function mice (Zhong et al., 2007). In contrast to 
nociceptors’ peripheral projections, the development of their 
central projections does not depend on NGF/TrkA signaling 
(Patel et al., 2000; Harrison et al., 2004; Zhong et al., 2007). 
Notably, we found that activation of B-RAF resulted in over-
growth of both proprioceptive and nociceptive axons in the 
spinal cord, whereas the expression of two known repulsive 
signaling molecules in the dorsal cord and DRG, Sema6 and 
PlexinA1, remained unaltered. Thus, kaB-RAF appears to acti-
vate a normally quiescent axon growth signaling pathway in the 
central sensory axons that seems to be unaffected by repulsive 
guidance cues.
The importance of this effect, the lack of response to re-
pulsive or inhibitory cues, becomes clear in the context of re-
generation of central sensory branches after dorsal root crush 
injury. Sensory axons expressing kaB-RAF robustly regener-
ated into the DREZ and spinal cord.
The regeneration failure of DRG axons after dorsal root 
avulsion injuries has been variously attributed to the lack of 
intrinsic growth capacity, to extrinsic growth barriers such as 
glia-associated growth inhibitors at the DREZ, and to prema-
ture synaptic differentiation (Han et al., 2012; Smith et al., 2012). 
Application of neurotrophic factors acting via tyrosine kinase 
receptors has shown substantially enhanced regeneration (Ramer 
et al., 2000; Wang et al., 2008; Harvey et al., 2010), even func-
tional recovery with the systemic administration of artemin 
(Wang et al., 2008), although these results await independent 
replication. Future studies will test whether a combination of 
RAF activation with trophic growth factors can further en-
hance axon regeneration and reinnervation of presumptive tar-
gets in the spinal cord.
Compared with spinal cord lesions, the optic nerve’s sim-
ple structure allows for clear evaluation of both lesion and re-
generation. In recent years, the optic nerve model has revealed 
several intracellular signaling pathways that can drive CNS 
axon regeneration, most prominently the PI3-kinase–mTOR 
and the JAK–STAT pathways, engaged by growth factor tyro-
sine kinase receptors and cytokines (Park et al., 2008; Smith 
et al., 2009; Buchser et al., 2012; Leibinger et al., 2013; Pernet 
et al., 2013). Combined deletion of endogenous inhibitors of 
these two pathways enhanced regeneration above the level 
reported for deletion of either gene alone (Sun et al., 2011). 
Activation of PI3-kinase–mTOR via PTEN deletion also en-
hanced regenerative growth in an SCI model (Liu et al., 2010), 
suggesting that results obtained in the optic nerve crush model 
may generally translate to SCI models. Here, we show that 
the classic growth factor signaling module RAF–MEK enables 
axon regeneration in the optic nerve at least as powerfully as 
any previously reported single molecule manipulation and that 
the combination of kaB-RAF with activation of PI3-kinase–
mTOR via PTEN deletion enhances optic nerve axon regen-
eration even more strongly than would be expected for a simple 
additive effect.812 B-RAF drives axon growth and regeneration | O’Donovan et al.
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